Geron reported $7.44M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Amgen AMGN:US $ 1.33B 99M
Bio Techne TECH:US $ 96.63M 3.45M
Cti Biopharma CTIC:US $ 21.59M 3.54M
Cytokinetics CYTK:US $ 42.72M 9.65M
Esperion Therapeutics ESPR:US $ 29.61M 772K
Exelixis EXEL:US $ 122.76M 19.9M
Genmab GEN:DC 633M 181M
Geron GERN:US $ 7.44M 744K
Gilead Sciences GILD:US $ 1.36B 274M
Macrogenics MGNX:US $ 13.67M 2.58M
Novartis NOVN:VX 3.59B 91M
Novavax NVAX:US $ 108.16M 12.17M
Pain Therapeutics PTIE:US $ 2.97M 54K
Seattle Genetics SGEN:US $ 220.26M 46.03M
YTE INCY:US $ 253.28M 43.69M